ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BOW Bowhead Specialty Holdings Inc

36.25
0.19 (0.53%)
27 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bowhead Specialty Holdings Inc NYSE:BOW NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.19 0.53% 36.25 36.48 35.72 36.11 397,213 01:00:00

Form 8-K - Current report

21/10/2024 10:09pm

Edgar (US Regulatory)


0002002473false00020024732024-10-212024-10-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 21, 2024
Bowhead Specialty Holdings Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-42111
87-1433334
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
452 Fifth Avenue
New York, New York 10018
(Address of principal executive offices)
(212) 970-0269
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareBOWNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 under the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02    Results of Operations and Financial Condition.
On October 21, 2024, Bowhead Specialty Holdings Inc. (the “Company”) issued a press release announcing certain preliminary unaudited financial results for the three months ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The Company will provide full third-quarter financial results during its previously announced earnings conference call at 8:30 a.m. Eastern Time on Tuesday, November 5, 2024. Quarterly earnings results will be released at approximately 7:00 a.m. Eastern Time on Tuesday, November 5, 2024.
Item 9.01.    Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 21, 2024
By:/s/ Brad Mulcahey
Name:Brad Mulcahey
Title:Chief Financial Officer and Treasurer
3

image.jpg




Bowhead Specialty Holdings Inc. Announces Preliminary Third Quarter 2024 Results

NEW YORK--(BUSINESS WIRE)-- Bowhead Specialty Holdings Inc. (NYSE: BOW), a growing specialty lines insurance group focused on providing casualty, professional liability and healthcare liability insurance products, today announced preliminary financial results for the third quarter ended September 30, 2024.

Preliminary Third Quarter 2024 Highlights
Gross written premiums are expected to increase 27% to 34% year over year to $193 million to $200 million.
Net income is expected to be between $11.5 million and $12.5 million, or $0.34 to $0.37 per diluted share.
Adjusted net income(1) is expected to be between $12 million and $13 million or $0.36 to $0.39 per diluted share(1).
Return on equity is expected to be between 13.0% and 14.0% and adjusted return on equity(1) is expected to be between 13.5% and 14.5%.
Book value per share is expected to be between $11.00 and $11.25 and diluted book value per share is expected to be between $10.80 and $11.00.
__________________
(1)     Non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measure to the most comparable U.S. GAAP measure.

Bowhead Chief Executive Officer Stephen Sills commented, “We are pleased to share our preliminary third quarter results. Additionally, since Bowhead does not write any property risks, we do not expect any material direct losses as a result of the recent hurricane activities. We look forward to sharing more about our third quarter results on November 5th.”

Preliminary Underwriting Results

The expected increase in gross written premiums of 27% to 34% year over year to $193 million to $200 million was driven by renewals, new business, and continued growth in our platform across all divisions.

Our Casualty division led the gross written premium growth with an approximately 40% increase year over year, which included a preliminary $4 million of additional gross written premium (a preliminary $3 million from a net earned premium basis) from an unusually large audit premium from one insured;
Healthcare Liability gross written premiums grew over 25% year over year;
Professional Liability gross written premiums grew over 10% year over year;
Late in the second quarter of 2024, we launched a new division called Baleen Specialty, which focuses on small, hard-to-place risks written 100% on a non-admitted basis. Baleen is a streamlined, low touch “flow” underwriting operation that supplements the “craft” solutions we offer. In line with our deliberate, measured and limited roll out, Baleen Specialty generated a preliminary $0.4 million of gross written premiums for the third quarter of 2024.

Our loss ratio is expected to be between 64.0% and 65.0% in the third quarter of 2024, which utilized the same industry loss ratios used since the fourth quarter of 2023. The expected decrease from 65.5% in the second quarter of 2024 was primarily driven by mix changes in the portfolio, as well as the large audit premium being fully earned and associated with older accident years with lower loss pick assumptions. There were no changes to loss picks or prior year reserves during the quarter. As of September 30, 2024, incurred but not reported liabilities comprised over 90% of our net loss reserves.

Our expense ratio is expected to be between 29.5% and 30.5% in the third quarter of 2024, which represents an expected decrease from 33.8% in the second quarter of 2024, or 32.3% excluding the one-time stock-based compensation acceleration expense of $1.3 million in the second quarter of 2024. The expected decrease was driven by continued prudent management of operating expenses, as well as the impact of the large audit premium increasing net earned premium.






image.jpg



Preliminary Investment Results

Net investment income is expected to be between $11 million and $12 million for the three months ended September 30, 2024. Our IPO proceeds were fully invested during the quarter and there were no changes to our investment strategy from the previous quarter.

Summary of Selected Preliminary Financial Results

The following table summarizes selected preliminary financial results for the three months ended September 30, 2024:

Three Months Ended September 30,
2024
($ in millions, except percentages and per share data)
Gross written premiums
$ 193 - 200
Net earned premiums
        104 - 107
Net investment income
            11 - 12
Total revenues
        114 - 119
Net income
      11.5 - 12.5
Key Operating and Financial Metrics:
Adjusted net income(1)
$ 12 - 13
Loss ratio64.0% - 65.0%
Expense ratio29.5% - 30.5%
Combined ratio93.5% - 95.5%
Return on equity(2)
13.0% - 14.0%
Adjusted return on equity(1)(2)
13.5% - 14.5%
Diluted earnings per share
$ 0.34 - 0.37
Diluted adjusted earnings per share(1)
$ 0.36 - 0.39
__________________
(1)Non-GAAP financial measure. See “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measure to the most comparable U.S. GAAP measure.
(2)For the three months ended September 30, 2024, preliminary net income and preliminary adjusted net income are annualized to arrive at preliminary return on equity and preliminary adjusted return on equity.
Reconciliation of Non-GAAP Financial Measures

This earnings release contains certain financial measures that are not presented in accordance with generally
accepted accounting principles in the United States (“U.S. GAAP”). We use these non-GAAP financial measures
when planning, monitoring and evaluating our performance. Management believes that each of the non-GAAP
financial measures described below provides useful insight into our underlying business performance.

Adjusted net income is defined as net income excluding the impact of net realized investment gains (losses), non-operating expenses, foreign exchange (gains) losses, and certain strategic initiatives. Adjusted net income excludes the impact of certain items that may not be indicative of underlying business trends, operating results, or future outlook, net of tax impact. We calculate the tax impact only on adjustments which would be included in calculating our income tax expense using the estimated tax rate at which we received a deduction for these adjustments.




image.jpg



Adjusted return on equity is defined as adjusted net income as a percentage of average beginning and ending mezzanine equity and stockholders’ equity.

Diluted adjusted earnings per share is defined as adjusted net income divided by the weighted average common shares outstanding for the period, reflecting the dilution that may occur if equity base awards are converted into common stock equivalents as calculated using the treasury stock method.

You should not rely on these non-GAAP financial measures as a substitute for any U.S. GAAP financial measure.
While we believe that these non-GAAP financial measures are useful in evaluating our business, this information
should be considered supplemental in nature and not as a replacement for or superior to the comparable U.S. GAAP
measures. In addition, other companies, including companies in our industry, may calculate such measures
differently, which reduces their usefulness as comparative measures.

Adjusted net income

Preliminary adjusted net income for the three months ended September 30, 2024 reconciles to preliminary net income as follows:

Three Months Ended September 30,
2024
Before income taxesAfter income taxes
($ in millions)
Income as reported
$ 15 - 16
$ 11.5 - 12.5
Adjustments(1)
                0 - 1
                0 - 1
Adjusted net income
$ 16 - 17
$ 12 - 13
_________________
(1)Adjustments include expected net realized investment gains (losses) of less than $0.1 million, non-operating expenses of approximately $0.5 million, and foreign exchange (gains) losses and strategic initiatives of less than $0.1 million. Estimated tax impact is applied to the “After income tax” column to arrive at adjusted net income.

Adjusted return on equity

Preliminary adjusted return on equity for the three months ended September 30, 2024 reconciles to preliminary return on equity as follows:

Three Months Ended September 30,
2024
($ in millions, except percentages)
Numerator: Adjusted net income(1)
$ 47 - 51
Denominator: Average mezzanine equity and stockholders' equity
            351 - 352
Adjusted return on equity
13.5% - 14.5%
________________
(1)For the three months ended September 30, 2024 preliminary net income and preliminary adjusted net income are annualized to arrive at preliminary return on equity and preliminary adjusted return on equity.



image.jpg




Diluted adjusted earnings per share

Preliminary diluted adjusted earnings per share for the three months ended September 30, 2024 reconciles to preliminary diluted earnings per share as follows:

Three Months Ended September 30,
2024
($ in millions, except per share data)
Numerator: Adjusted net income
$ 12 - 13
Denominator: Diluted weighted average shares outstanding
33
Diluted adjusted earnings per share
$ 0.36 - 0.39

About Bowhead Specialty Holdings Inc.

Bowhead Specialty is a growing specialty insurance business providing casualty, professional liability and healthcare liability insurance products. We were founded and are led by industry veteran Stephen Sills. The team is composed of highly experienced and respected industry veterans with decades of individual, successful underwriting and management experience. We focus on providing “craft” solutions in our specialty lines and classes of business that we believe require deep underwriting and claims expertise in order to produce attractive financial results.

We pride ourselves on the quality and experience of our people, who are committed to exceeding our partners’ expectations through excellent service and expertise. Our collaborative culture spans all functions of our business and allows us to provide a consistent, positive experience for all of our partners.

Conference Call

The Company will host a conference call to discuss its results on Tuesday, November 5, 2024, beginning at 8:30 a.m. Eastern Time. Interested parties may access the conference call through a live webcast, which can be accessed via this link, by visiting the Company’s Investor Relations website, or by dialing (877) 407-3949 (toll-free) or (215) 268-9917 (international). Please join the live webcast or dial in at least 10 minutes before the start of the call.

A replay of the event webcast will be available on the company’s Investor Relations website for one year following the call.

Forward-Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in press release are forward-looking statements. In some cases, forward-looking statements can be identified by terms such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “seeks,” “future,” “outlook,” “prospects” “will,” “would,” “should,” “could,” “may,” “can have” or similar words. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. These risks and uncertainties include, but are not limited to, those described in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024 and any subsequent filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events or otherwise.

Investor Relations Contact:
Shirley Yap, Head of Investor Relations
investorrelations@bowheadspecialty.com

v3.24.3
Cover
Oct. 21, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Oct. 21, 2024
Registrant Name Bowhead Specialty Holdings Inc.
Entity Address, Address Line One 452 Fifth Avenue
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10018
Local Phone Number 970-0269
City Area Code 212
Entity File Number 001-42111
Entity Tax Identification Number 87-1433334
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Incorporation, State or Country Code DE
Written Communications false
Trading Symbol BOW
Security Exchange Name NYSE
Central Index Key 0002002473
Amendment Flag false

1 Year Bowhead Specialty Chart

1 Year Bowhead Specialty Chart

1 Month Bowhead Specialty Chart

1 Month Bowhead Specialty Chart

Your Recent History

Delayed Upgrade Clock